PDE5A and myocardial infarction: Our recent study focused on prolonging the effective inhibition of PDE5a, and results demonstrated that PDE5a inhibition using an adenoviral vector inserted into the shRNA sequence could improve cardiac function and remodeling[11], as well as increase capillary density and capillary/myocyte ratio in our MI mouse model.